New acute pain pill tested in humans for first time

NCT ID NCT07412938

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage study tested a new drug called JKN2306 in 44 healthy adults in China. The main goal was to see if single doses are safe and how the body processes the drug, including the effect of food. This trial does not test whether the drug actually relieves pain.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

JKN2306

What this could lead to

If safe and well-tolerated, this could pave the way for future studies testing JKN2306 as a treatment for acute pain.

What could go wrong

This is a very early, small Phase 1 study in healthy people, not patients. It only checks safety and drug processing, not whether it actually relieves pain. Many early-stage drugs fail in later trials.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Acute Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • China-Japan Friendship Hospital

    Beijing, Beijing Municipality, 214000, China